Circulating tumor cells (CTCs), molecular alterations and their correlation with characteristics of patients (pts) with metastatic colorectal cancer (mCRC) treated in the Spanish TTD VISN & Uacute; Program
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- de la Orden, V
- Martinez, A
- Bando, I
- Santamaria, I
- Paricio, BB
- Peligros, I
- Mediero, B
- Llovet, P
- Moreno, V
- Vieitez, JM
- Garcia-Alfonso, P
- Morales, MJO
- Salvia, MAS
- Quintero, G
- Gesto, FA
- Aguilar, EA
- Rubio, ED
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Proyectos y Estudios Clínicos
NEUROBLASTO VAL: INVESTIGACION BASICA Y TRASLACIONAL DE LA TERAPIA DEL NEUROBLASTOMA DE ALTO RIESGO.
Investigador Principal: VICTORIA CASTEL SÁNCHEZ
41/09 . GENT PER GENT . 2010
COMPREHENSIVE, INTEGRATIVE AND GENOMIC APPROACH TO THE UNDERSTANDING AND TREATMENT OF CANCER AND LEUKEMIA.
Investigador Principal: MIGUEL ÁNGEL SANZ ALONSO
PIE13/00046 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2014
SISTEMA DE DETECCION DE BIOMARCADORES ONCOLOGICOS PARA TRATAMIENTO PERSONALIZADO DEL CANCER COLORRECTAL (ONCOMARKER).
Investigador Principal: SARAI PALANCA SUELA
RTC-2015-3625-1 . MINISTERIO DE ECONOMIA Y COMPETITIVIDAD . 2015
Cita
Sastre,J,de la Orden,V,Martinez,A,Bando,I,Santamaria,I,Paricio,BB,Palanca,S et al. Circulating tumor cells (CTCs), molecular alterations and their correlation with characteristics of patients (pts) with metastatic colorectal cancer (mCRC) treated in the Spanish TTD VISN & Uacute; Program. 42nd European-Society-for-Medical-Oncology Congress (ESMO). 2017. Madrid. GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND:OXFORD UNIV PRESS. 2017.